Indicator Explainer
TP63 Gene
This gene plays a role in both transcriptional regulation and limb development.
This page explains what the indicator is and how results are interpreted in general terms. Reference ranges depend on the laboratory, the method, and your own situation — no single “normal value” applies to everyone. This page is health information, not a diagnosis. For symptoms, treatment, or urgent concerns, contact a healthcare professional.
When it is tested
Source: National Cancer Institute, NCI Thesaurus 26.09d, C91791. NCI definition, reproduced without modification under CC BY 4.0. Source identity and definition checked automatically on 2026-10-20. No individual clinical interpretation or human reviewer is asserted.
Reading results
Reference intervals and interpretation depend on the laboratory, specimen, method and clinical context. This source definition is educational information; it does not establish a diagnosis, product approval or suitability for an individual.
Also Known As
References
- NCI Thesaurus 26.09d — TP63 Gene (C91791)
- Source: National Cancer Institute, NCI Thesaurus 26.09d, C91791. NCI definition, reproduced without modification under CC BY 4.0.
- A Splice Site Variation in the TP63 Gene Leads to Mild Atypical EEC3 in a Large Chinese Family. — Int J Dermatol, 2026-08-02 (PMID 42544019; literature)
- A case of Rapp-Hodgkin syndrome featuring prominent oral leukokeratosis linked to a TP63 gene variant. — BMC Oral Health, 2026-04-30 (PMID 42057083; literature)
- Correction to "De Novo Missense Variant in TP63 Gene: Insights on Clinical and Molecular Investigations". — J Gene Med, 2026-04-01 (PMID 41978959; literature)
- De Novo Missense Variant in TP63 Gene: Insights on Clinical and Molecular Investigations. — J Gene Med, 2025-11-01 (PMID 41264930; literature)